PREDICTORS OF DISEASE FLARE AFTER DISCONTINUATION OF CONCOMITANT METHOTREXATE IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB

被引：0
|
作者：
Asai, S. [1 ]
Takahashi, N. [1 ]
Kuwatsuka, Y. [2 ]
Ando, M. [2 ]
Ishiguro, N. [1 ]
Kojima, T. [1 ]
机构：
[1] Nagoya Univ, Dept Orthoped Surg, Grad Sch Med, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Adv Med, Nagoya, Aichi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0088
引用
收藏
页码：252 / 253
页数：2
相关论文
共 50 条
  • [41] Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
    Pers, Yves-Marie
    Fortunet, Clementine
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    De Jong, Audrey
    Mercier, Gregoire
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Marotte, Hubert
    Maillefert, Jean-Francis
    RHEUMATOLOGY, 2014, 53 (01) : 76 - 84
  • [42] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [43] Risk of Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Treated with Methotrexate
    Wan, Joy
    Zhang, He
    Ogdie, Alexis
    Egeberg, Alexander
    Gelfand, Joel M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 12 - 12
  • [44] Predictors of Clinical Response and Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Methotrexate Monotherapy
    Drouin, Julie
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1405 - 1410
  • [45] PREDICTORS OF DISEASE COURSE AFTER THE DISCONTINUATION OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH LONG-TERM REMISSION
    Kadar, G.
    Czibula, A.
    Szalay, B.
    Nagy, K.
    Pusztai, A.
    Balog, A.
    Monostori, E.
    Vasarhelyi, B.
    Szekanecz, Z.
    Kovacs, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1007 - 1007
  • [46] Incidence of malignancies in Japanese rheumatoid arthritis patients treated with tocilizumab in comparison to those in an observational cohort of Japanese patients and a Japanese population database
    Yamanaka, H.
    Nishimoto, N.
    Inoue, E.
    Hara, M.
    Tomatsu, T.
    Kamatani, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 123
  • [47] Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
    Udachkina, E. V.
    Novikova, D. S.
    Popkova, T. V.
    Panasyuk, E. Yu.
    Avdeeva, A. S.
    Volkov, A. V.
    Kirillova, I. G.
    Markelova, E. I.
    Aleksandrova, E. N.
    Novikov, A. A.
    Nasonov, E. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (05) : 510 - 516
  • [48] SURVIVAL AND DRUG DISCONTINUATION ANALYSES IN A LARGE COHORT OF METHOTREXATE-TREATED RHEUMATOID-ARTHRITIS PATIENTS
    ALARCON, GS
    TRACEY, IC
    STRAND, GM
    SINGH, K
    MACALUSO, M
    ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (09) : 708 - 712
  • [49] Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab
    Hirao, M.
    Hashimoto, J.
    Tsuboi, H.
    Nampei, A.
    Nakahara, H.
    Yoshio, N.
    Mima, T.
    Yoshikawa, H.
    Nishimoto, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 654 - 657
  • [50] Discontinuation Rates Of Tocilizumab Therapy In Rheumatoid Arthritis Patients In a Nonacademic Clinical Setting
    Manohar, Jaishree
    Pritchard, Charles H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S626 - S626
12345